CureVac N.V.
NasdaqGM:CVAC
$ 12.62
$-4.81 (-27.60%)
$ 12.62
$-4.81 (-27.60%)
End-of-day quote: 07/15/2022

CVAC - CureVac N.V. Stock Prediction 2025 - 2030

For CureVac N.V. the 5 year risk analysis shows 0 out of 0 areas green. In the TopGraphs chart you can see if NasdaqGM:CVAC is undervalued. If the price is below the blue line, this is a buy signal for the CVAC stock.

$13.00
Forecast 2022
$16.27
Forecast 2025
$23.63
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2022
$13.00
Forecast 2025
$16.27
Forecast 2030
$23.63
TopGraphs Quality Ranking
Underperform

CureVac N.V. Stock Forecast 2022

$18.47

In the last five quarters, CureVac N.V.'s Price Target has risen from $0.00 to $12.62 - an astounding 100% increase. One analysts predict that CureVac N.V.'s share price will increase moderately in the coming year, reaching 18.47. This would represent an increase of 46.35%.

46.35%
46.35

Highest Price Target $49.32

Average Price Target $18.47

Lowest Price Target $14.42

CureVac N.V. Stock Forecast 2025

Stock Prediction for the Price of One CureVac N.V. Share in Jan 2025.

In Jan 2025 analysts predict a share price of $15.19. An increase of 20.4% compared to today's share price.

Stock Prediction for the Price of One CureVac N.V. Share in Feb 2025.

In Feb 2025 analysts predict a share price of $15.29. An increase of 21.18% compared to today's share price.

Stock Prediction for the Price of One CureVac N.V. Share in Mar 2025.

In Mar 2025 analysts predict a share price of $15.39. An increase of 21.95% compared to today's share price.

Stock Prediction for the Price of One CureVac N.V. Share in Apr 2025.

In Apr 2025 analysts predict a share price of $15.49. An increase of 22.72% compared to today's share price.

Stock Prediction for the Price of One CureVac N.V. Share in May 2025.

In May 2025 analysts predict a share price of $15.58. An increase of 23.49% compared to today's share price.

Stock Prediction for the Price of One CureVac N.V. Share in Jun 2025.

In Jun 2025 analysts predict a share price of $15.68. An increase of 24.27% compared to today's share price.

Stock Prediction for the Price of One CureVac N.V. Share in Jul 2025.

In Jul 2025 analysts predict a share price of $15.78. An increase of 25.04% compared to today's share price.

Stock Prediction for the Price of One CureVac N.V. Share in Aug 2025.

In Aug 2025 analysts predict a share price of $15.88. An increase of 25.81% compared to today's share price.

Stock Prediction for the Price of One CureVac N.V. Share in Sep 2025.

In Sep 2025 analysts predict a share price of $15.97. An increase of 26.58% compared to today's share price.

Stock Prediction for the Price of One CureVac N.V. Share in Oct 2025.

In Oct 2025 analysts predict a share price of $16.07. An increase of 27.36% compared to today's share price.

Stock Prediction for the Price of One CureVac N.V. Share in Nov 2025.

In Nov 2025 analysts predict a share price of $16.17. An increase of 28.13% compared to today's share price.

Stock Prediction for the Price of One CureVac N.V. Share in Dec 2025.

In Dec 2025 analysts predict a share price of $16.27. An increase of 28.9% compared to today's share price.

CureVac N.V. Stock Predictions 2030

CureVac N.V. Stock Predictions for Jan 2030.

In January 2030 analysts predict a stock price of $22.07. An increase of 74.87% compared to the previous month's estimate.

CureVac N.V. Stock Predictions for Feb 2030.

In February 2030 analysts predict a stock price of $22.21. An increase of 76% compared to the previous month's estimate.

CureVac N.V. Stock Predictions for Mar 2030.

In March 2030 analysts predict a stock price of $22.35. An increase of 77.12% compared to the previous month's estimate.

CureVac N.V. Stock Predictions for Apr 2030.

In April 2030 analysts predict a stock price of $22.49. An increase of 78.24% compared to the previous month's estimate.

CureVac N.V. Stock Predictions for May 2030.

In May 2030 analysts predict a stock price of $22.64. An increase of 79.36% compared to the previous month's estimate.

CureVac N.V. Stock Predictions for Jun 2030.

In June 2030 analysts predict a stock price of $22.78. An increase of 80.48% compared to the previous month's estimate.

CureVac N.V. Stock Predictions for Jul 2030.

In July 2030 analysts predict a stock price of $22.92. An increase of 81.61% compared to the previous month's estimate.

CureVac N.V. Stock Predictions for Aug 2030.

In August 2030 analysts predict a stock price of $23.06. An increase of 82.73% compared to the previous month's estimate.

CureVac N.V. Stock Predictions for Sep 2030.

In September 2030 analysts predict a stock price of $23.20. An increase of 83.85% compared to the previous month's estimate.

CureVac N.V. Stock Predictions for Oct 2030.

In October 2030 analysts predict a stock price of $23.34. An increase of 84.97% compared to the previous month's estimate.

CureVac N.V. Stock Predictions for Nov 2030.

In November 2030 analysts predict a stock price of $23.49. An increase of 86.1% compared to the previous month's estimate.

CureVac N.V. Stock Predictions for Dec 2030.

In December 2030 analysts predict a stock price of $23.63. An increase of 87.22% compared to the previous month's estimate.

Company Info

P/E Ratio
0.0
Beta
0.00
Price-to-book Ratio
3.39
Market Cap
2.36B
TEV
N/A
LT Debt/Cap
N/A
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$0.00
Country
Website

About CureVac N.V.

CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

CureVac N.V. Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y
P/E Ratio
0.0
Beta
0.00
Price-to-book Ratio
3.39
Market Cap
2.36B
TEV
N/A
LT Debt/Cap
N/A
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$0.00
Country
Website

Financials

Year Year TTM 2020
Rev. Revenue
N/A 48.87
GM % Gross Margin %
N/A 71.1
OI Operating Income
N/A -133.55
OM Operating Margin
N/A -273.27
NI Net Income
N/A -129.12
EPS % Earnings Per Share %
N/A -1.93 -0.98
Div. Dividends
N/A 0.00
PR % Payout Ratio %
N/A 0
Sha. Shares
N/A 180
OCF Operating Cash Flow
N/A 522
CS Cap Spending
N/A -36
FCF Free Cash Flow
N/A 486
FCFS Free Cash Flow Per Share
N/A 3.59

CureVac N.V. Analyst Ratings Frequently Asked Questions

Who are the analysts watching CureVac N.V.?

The following analysts have recently covered CureVac N.V.:

Berenberg
BofA Global Research
Deutsche Bank
Guggenheim Securities, LLC
Jefferies LLC
JMP Securities
Marktfeld
Morningstar Inc.
(This information refers to the last 90 days.)

Who are the sell-side analysts watching CureVac N.V.?

The following sell-side analysts have recently covered CureVac N.V.:

Shu, Zhiqiang
Meacham, Geoffrey Christopher
Papadakis, Emmanuel Douglas
Fernandez, Seamus Christopher
Yang, Eun Kyung
Buchanan, Douglas Royal
Paraskevopoulos, Michail
Elfman, Rachel
(This information refers to the last 90 days.)

© Copyright 2022 | TopGraphs™ | All Rights Reserved

To use TopGraphs™, you must accept our Terms and Conditions and Privacy Policy